AISF position paper on HCV in immunocompromised patients

Dig Liver Dis. 2019 Jan;51(1):10-23. doi: 10.1016/j.dld.2018.09.022. Epub 2018 Oct 1.

Abstract

This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.

Keywords: HCV; Immunocompromised patients; Organ transplant.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Comorbidity
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / epidemiology
  • Hepatitis C, Chronic / therapy*
  • Humans
  • Immunocompetence
  • Immunocompromised Host*
  • Italy / epidemiology
  • Neoplasms / complications
  • Transplant Recipients

Substances

  • Antiviral Agents